We are live on ! Find out more
USNA icon

Usana Health Sciences

145 hedge funds and large institutions have $648M invested in Usana Health Sciences in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 44 increasing their positions, 47 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 13

11% more funds holding

Funds holding: 131145 (+14)

6% more capital invested

Capital invested by funds: $611M → $648M (+$37.1M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

6% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 47

4.59% less ownership

Funds ownership: 96.84%92.26% (-4.6%)

Holders
145
Holders Change
+14
Holders Change %
+10.69%
% of All Funds
3.86%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
44
Reduced
47
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$111M -$15.1M -293,696 -13%
Renaissance Technologies
2
Renaissance Technologies
New York
$91.3M +$2.43M +47,400 +3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$54.7M +$6.91M +134,826 +16%
Schroder Investment Management Group
4
Schroder Investment Management Group
United Kingdom
$38.8M -$1.39M -27,116 -4%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$38.5M
BIT
6
BlackRock Institutional Trust
California
$20.1M -$869K -16,962 -4%
LSV Asset Management
7
LSV Asset Management
Illinois
$18.4M -$10.3K -200 -0.1%
BFA
8
BlackRock Fund Advisors
California
$16.7M +$223K +4,346 +1%
HA
9
Hays Advisory
Tennessee
$12.5M +$11.5M +224,352 New
Bank of New York Mellon
10
Bank of New York Mellon
New York
$11M +$5.47M +106,708 +118%
Deutsche Bank
11
Deutsche Bank
Germany
$10.8M -$357K -6,964 -3%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$10.7M +$2.22M +43,392 +29%
State Street
13
State Street
Massachusetts
$10.6M -$7.38K -144 -0.1%
Northern Trust
14
Northern Trust
Illinois
$10.5M +$55.7K +1,086 +0.6%
JP Morgan Chase
15
JP Morgan Chase
New York
$10M -$607K -11,848 -6%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$8.76M +$241K +4,710 +3%
AQR Capital Management
17
AQR Capital Management
Connecticut
$8.37M +$3.22M +62,734 +71%
Morgan Stanley
18
Morgan Stanley
New York
$8.16M -$5.11M -99,750 -40%
Norges Bank
19
Norges Bank
Norway
$7.81M
SI
20
Sensato Investors
California
$6.66M +$6.15M +119,944 New
Charles Schwab
21
Charles Schwab
California
$4.77M +$570K +11,122 +15%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$4.57M -$2.72M -53,054 -39%
Arrowstreet Capital
23
Arrowstreet Capital
Massachusetts
$4.53M +$178K +3,466 +4%
QI
24
QS Investors
New York
$4.36M
Allianz Asset Management
25
Allianz Asset Management
Germany
$4.24M -$91.2K -1,780 -2%

USNA Hedge Fund Activity: Q1 2015 in Review

145 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2015, worth a combined $648M — up 6.1% from $611M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new USNA positions and 13 closed out — a net gain of 14 holders — while 44 added to existing stakes and 47 trimmed.

The largest buyer was Hays Advisory, opening a new position worth an estimated $11.5M. The largest seller was Fidelity Investments, cutting an estimated $15.1M.

  • 145 institutional investors held Usana Health Sciences (USNA) as of Q1 2015, up from 131 in Q4 2014.
  • Funds reported $648M of Usana Health Sciences stock for Q1 2015, up 6.1% quarter-over-quarter.
  • 27 funds opened new Usana Health Sciences positions in Q1 2015 and 13 closed out, a net change of +14 holders.
  • The largest Usana Health Sciences buyer in Q1 2015 was Hays Advisory, an estimated $11.5M added.
  • The largest Usana Health Sciences seller in Q1 2015 was Fidelity Investments, an estimated $15.1M sold.

Based on aggregated 13F filings for Q1 2015.